SEARCH HEALTH CONDITIONS BY ALPHABETS
Factor XIII Deficiency
Medications for Factor XIII Deficiency
About Factor XIII Deficiency: Factor XIII deficiency is an inherited bleeding disorder. Variable XIII is produced by Your system than it needs to, or the variable XIII is not working correctly the clotting reaction is obstructed and the blood clot doesn`t form.
Drugs Used in the Treatment of Factor XIII Deficiency
The following listing of medications come somehow related to, or used at the treatment of this particular condition.
| Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| Corifact | Rx | C | N | Inch inspection | 10 | ||
Generic title: variable XIII systemic Drug class: miscellaneous coagulation modifiers For customers: dose, interactions, and side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
| Tretten | Rx | C | N | Add inspection | 0.0 | ||
Generic title: variable XIII systemic Drug class: miscellaneous coagulation modifiers For customers: dose, interactions, and side effects For professionals: AHFS DI Monograph | |||||||
| variable XIII | Rx | C | N | Inch inspection | 10 | ||
Generic title: variable XIII systemic Brand names: Corifact, Tretten Drug class: miscellaneous coagulation modifiers For customers: dose, interactions, For professionals: az Drug Facts, AHFS DI Monograph | |||||||
Legend
| Rx | Prescription Only |
|---|---|
| OTC | On The Counter |
| Rx/OTC | Prescription or Over the Counter |
| Away Prizes | This medication may not be accepted by the FDA for treating the particular condition. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to present a risk to the fetus within the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in elderly women. |
| C | Animal reproduction studies have demonstrated a negative effect in the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with use in elderly women obviously outweigh potential gains. |
| N | FDA has not classified the medication. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | Is not at the mercy of the Controlled Substances Act. |
| Inch | includes a high potential for misuse. Has no accepted medical use in treatment in the USA. There is a lack of accepted safety for use under medical supervision. |
| 2 | includes a high potential for misuse. Has a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the USA. Abuse may lead to severe physical or emotional dependence. |
| 3 | features a potential for abuse less than people in schedule 2 and 1. Has a currently accepted medical use in treatment in the USA. Abuse may lead to physical dependence or high psychological dependence. |
| 4 | includes a very low potential for abuse in accordance with those in schedule 3. It`s a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence. |
| 5 | includes a very low potential for abuse in accordance with those in schedule 4. Has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
| Infection | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Dtc
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always seek advice from your healthcare provider to be sure the information relates to your personal circumstances.
- Fabry Disease
- Facial Fat Loss
- Facial Lipoatrophy
- Facial Wasting
- Factor IX Deficiency
- Factor IX Hemophilia
- Factor VII Deficiency
- Factor X Deficiency
- Factor XIII Deficiency
- Fallopian Tube Cancer
- Familial Cold Autoinflammatory Syndrome
- Familial Cold Urticaria
- Familial Hibernian Fever
- Familial Hypophosphatemia
- Familial Periodic Paralysis
- Familial Pulmonary Arterial Hypertension
- Family History of Cerebrovascular Disease
- Family History of Musculoskeletal Disorder
- Family History of Myocardial Infarction
- Fasciculations
- Fascioliasis
- Fasciolopsis Buski, Intestinal Fluke
- Fasting Blood Sugar
Top USA Pharma Companies
Popular Categories
Health Condition
- Fabry Disease
- Facial Fat Loss
- Facial Lipoatrophy
- Facial Wasting
- Factor IX Deficiency
- Factor IX Hemophilia
- Factor VII Deficiency
- Factor X Deficiency
- Factor XIII Deficiency
- Fallopian Tube Cancer
- Familial Cold Autoinflammatory Syndrome
- Familial Cold Urticaria
- Familial Hibernian Fever
- Familial Hypophosphatemia
- Familial Periodic Paralysis
- Familial Pulmonary Arterial Hypertension
- Family History of Cerebrovascular Disease
- Family History of Musculoskeletal Disorder
- Family History of Myocardial Infarction
- Fasciculations
- Fascioliasis
- Fasciolopsis Buski, Intestinal Fluke
- Fasting Blood Sugar
Easily find an affordable health insurance plan
